Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
D 2.18 -5.63% -0.13
CRBP closed down 5.63 percent on Friday, February 26, 2021, on 44 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical CRBP trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.63%
Wide Bands Range Expansion -5.63%
Down 3 Days in a Row Weakness -5.63%
Older End-of-Day Signals for CRBP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Fell Below Previous Day's Low 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Fibrotic Diseases Treatment Of Cystic Fibrosis Scleroderma Channelopathies

Is CRBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.78
52 Week Low 0.91
Average Volume 16,455,008
200-Day Moving Average 4.02
50-Day Moving Average 2.03
20-Day Moving Average 2.71
10-Day Moving Average 2.69
Average True Range 0.37
ADX 35.5
+DI 19.54
-DI 26.23
Chandelier Exit (Long, 3 ATRs ) 2.89
Chandelier Exit (Short, 3 ATRs ) 2.86
Upper Bollinger Band 3.47
Lower Bollinger Band 1.96
Percent B (%b) 0.15
BandWidth 55.83
MACD Line 0.12
MACD Signal Line 0.24
MACD Histogram -0.1295
Fundamentals Value
Market Cap 183.2 Million
Num Shares 84 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -2.34
Price-to-Sales 16.46
Price-to-Book 3.82
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.58
Resistance 3 (R3) 2.61 2.51 2.51
Resistance 2 (R2) 2.51 2.40 2.49 2.49
Resistance 1 (R1) 2.34 2.34 2.29 2.31 2.47
Pivot Point 2.24 2.24 2.22 2.23 2.24
Support 1 (S1) 2.08 2.14 2.03 2.05 1.89
Support 2 (S2) 1.98 2.08 1.96 1.87
Support 3 (S3) 1.81 1.98 1.85
Support 4 (S4) 1.78